© Reuters. FILE PHOTO: A box of Johnson & Johnson’s coronavirus disease (COVID-19) vaccines is seen at the Forem vaccination centre in Pamplona, Spain, April 22, 2021. REUTERS/Vincent West/File Photo
BRUSSELS (Reuters) – The European Commission said on Monday that the reduction in deliveries of COVID-19 vaccines from Johnson & Johnson (NYSE:) to EU member states was only temporary, and the company was still due to meet its contract for total doses by the end of this year.
“Member states were informed of certain delays when it comes to the delivery of Johnson & Johnson shots, and they expressed their concern,” a spokesman for the European Union executive told a news conference.
“The way we understand it is that this is a temporary reduction in deliveries and we can expect to see an increase in deliveries of doses soon. We’re still working on the basis of the hypothesis that we’re going to have the number of doses agreed on the whole, the second and third quarters.”
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.